Jens Juul Holst

Jens Juul Holst

Professor

ORCID: 0000-0001-6853-3805

Publication year:
All
21 - 30 out of 33Page size: 10
  1. Published

    Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre

    Thulesen, J., Hartmann, Bolette, Nielsen, C., Holst, Jens Juul & Poulsen, Steen Seier, Nov 1999, In: Gut. 45, 5, p. 672-8 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Glucagon-like peptide-1: a basis for new approaches to the management of diabetes

    Deacon, Carolyn F., Holst, Jens Juul & Carr, R. D., Mar 1999, In: Drugs of Today. 35, 3, p. 159-70 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Glucagon-like peptide-1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential

    Holst, Jens Juul, 1999, In: Trends in Endocrinology and Metabolism. 10, p. 229-235

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Impaired meal-stimulated glucagon-like peptide-2 responses in short bowel patients with intestinal failure

    Jeppesen, P. B., Hansen, B. S., Hartmann, B., Holst, Jens Juul & Mortensen, P. B., 1999, In: Gut. 45, p. 559-563

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Differential effects of saturated and monounsaturated fat on postprandial lipaemia and GIP/GLP-1 response in healthy subjects

    Thomsen, C., Rasmussen, O., Lousen, T., Hermansen, K. & Holst, Jens Juul, 1999, In: Am. J. Clin. Nutri.. 69, p. 1135-1143

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Inhibition of shamfeeding stimulated human gastric acid secretion by glucagon-like peptide-2

    Wøjdemann, M., Wettergren, A., Hartmann, B., Hilsted, L. M. & Holst, Jens Juul, 1999, In: J. Clin. Endocrinol. Metab.. 84, p. 2513-2517

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients

    Toft-Nielsen, M. B., Madsbad, S. & Holst, Jens Juul, 1999, In: Diabetes Care. 22, p. 1137-1143

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Diabetic Intestinal Growth Adaptation and glucagon-like peptide 2 (GLP-2) in the rat. Effect of dietary fibres

    Thulesen, J., Hartmann, B., Nielsen, C., Holst, Jens Juul & Poulsen, S. S., 1999, In: Gut. 45, p. 672-678

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Octreotide suppresses the incretin GLP-1 in patients with acromegally, clinically nonfunctioning pituitary tumours and in healthy subjects

    Plöckinger, U., Holst, Jens Juul, Messerschmidt, D., Hopfenmüller, W. & Quabbe, H. J., 1999, In: European Journal of Endocrinology. 140, p. 538-544

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Proglucagon cleavage profile in canine L-cells expressing endogenous PC-1/3 and PC-2

    Damholt, A. B., Buchan, A. M. J., Holst, Jens Juul & Kofod, H., 1999, In: Endokrinologiya. 140, p. 4800-4808

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 4207